Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Product Name: Tirzepatide Classification: Dual GIP/GLP-1 Receptor Agonist Structural Description: 39-amino acid dual GIP/GLP-1 receptor agonist CAS Number: 2023788-19-2 Molecular Weight: 4813.45 g/mol Purity: 99% (verified by HPLC and Mass Spectrometry) Physical Form: Lyophilized (freeze-dried) powder Intended Use: In-vitro research use only not for human consumption Related research compounds Comparable catalog records with published variants and certificate status
What is a KLOW dosage chart
The two FDA approved doses are 1.7mg per week and 2.4mg per week administered subcutaneously on designated days each week, either Monday or Thursday
SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity
This helps us determine the most effective treatment plan for you
Supporting healthy GLP-1 levels can help with weight management and metabolic health
US$ 25.74
US$ 21.86
US$ 21.98
US$ 22.34
US$ 24.75
US$ 26.25
